I
Immatics biotechnologies
Biotech & Life Sciences · Tübingen, Germany · Founded 2000 · Public via SPAC 2020
Talent graph
Immatics biotechnologies's talent
Source: Dealroom Talent Intelligence.
Investors
17 investors on Immatics biotechnologies's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.
Immatics biotechnologies mafia
Startups founded by Immatics biotechnologies alumni
Former Immatics biotechnologies employees who went on to start their own companies. Sorted by Dealroom signal score.
Global footprint
Where Immatics biotechnologies has talent and traffic
team presence
across markets
Patent intelligence
$272M patent portfolio · 204 active families
Where Immatics biotechnologies concentrates vs peers
Each axis is a top-10 topic across Immatics biotechnologies and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Immatics biotechnologies
An AI-synthesized read of the highest-engagement posts about Immatics biotechnologies on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Immatics biotechnologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.